18 reports

  • Residential Substance Abuse and Mental Health Facilities Market Characteristics

Pyschiatric Hospitals specialize in the treatment of serious mental disorders such as clinical depression, schizophrenia, and bipolar disorder.

  • Addiction Disorder
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • EXECUTIVE SUMMARY
  • Products & Markets

The most common services provided are the treatment of schizophrenic and psychotic disorders, mood disorders such as depression, mania and bipolar disorder, anxiety disorders and personality disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • Products and services segmentation (2019)
  • Products & Markets

The vast majority of mood disorders are categorized as either depressive disorders or bipolar disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • PRODUCTS & SERVICES CONTINUED

Mood disorders include depressive disorder, dysthymic disorder and bipolar disorder; the NIMH estimates that ##. ##% of Americans over the age of ## suffer from these types of mental illnesses.

  • Addiction Disorder
  • Health Care Provider
  • Mental Health
  • United States
  • Forecast
  • Products & Markets

In addition, individuals with a bipolar disorder (i. e. manic depression) who maintain a regimen of lithium are much less likely to relapse than those not taking the medication.

  • Addiction Disorder
  • Ambulatory Care
  • Mental Health
  • United States
  • Demand
  • Target
  • Clinical Trial profile. 315 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Clinical Trial
  • Opioid
  • World
  • Alkermes plc

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Asthma
  • Pharmaceutical
  • United States
  • Product Initiative

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Asthma
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Clinical Trial profile. 216 Trial Title
  • Target

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World

The company' s lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder.

  • Addiction Disorder
  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Pulmonary Delivery
  • Target
  • Clinical Trial profile. 74 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Antiseptics
  • Asthma
  • World
  • Alkermes plc

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Merck & Co Inc Adamis Pharmaceuticals Corp ##M Drug Delivery Systems Axis Clinical Trials As

  • Asthma
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

Its CNS portfolio includes Azilect for the treatment of symptoms of Parkinson' s disease; Copaxone for multiple sclerosis; Nuvigil for sleep disorders; and several novel therapies for the treatment of pain.

  • Asthma
  • Pharmaceutical
  • Company Financials
  • Market Size
  • Teva Pharmaceutical Industries Ltd.

Reviva Pharma' s product RP## is also been developing for Parkinson' s psychosis, attention deficit hyperactivity disorder, bipolar disorder, major depressive disorder, Alzheimer' s psychosis and agitation, and autism spectrum.

  • Asthma
  • Autoimmune Disease
  • United States
  • Product Initiative
  • ProMetic Life Sciences Inc.

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Asthma
  • Drug Development
  • United States
  • MediciNova, Inc.

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Asthma
  • United States
  • Product Initiative
  • MediciNova, Inc.

Reviva Pharma' s product RP## is also been developing for Parkinson' s psychosis, attention deficit hyperactivity disorder, bipolar disorder, major depressive disorder, Alzheimer' s psychosis and agitation, and autism spectrum.

  • Asthma
  • Pharmaceutical
  • Company
  • Product Initiative
  • AstraZeneca PLC

SK Biopharmaceuticals Co., Ltd. is developing SKL-PSY for the treatment of depression and bipolar disorder.

  • Addiction Disorder
  • Biopharmaceutical
  • Research And Development
  • Therapy
  • SK Biopharmaceuticals Co., Ltd.